Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600314 · ClinicalTrials.gov registry record
Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease
A clinical trial, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- 20
- Enrollment target
NCT00600314 is a clinical trial that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 20 participants.
The verdict
NCT00600314 has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study aims to show that the MedGem indirect calorimetry measurement device will be feasible to use in children with GVHD. Also, it aims to show that children with chronic GVHD will have elevated REE that is not adequately predicted by standard equations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-04 |
| Est. Completion | 2010-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00600314
The ClinicalTrials.gov registry entry for NCT00600314 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00600314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00600314 about?
NCT00600314 is a clinical study titled "Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease". This study aims to show that the MedGem indirect calorimetry measurement device will be feasible to use in children with GVHD. Also, it aims to show that children with chronic GVHD will have elevated REE that is not adequately predicted by standard equations.
What is the current status of trial NCT00600314?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2005-04. Estimated completion is 2010-09.
Who is sponsoring clinical trial NCT00600314?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.